Synapse - Ferrata Storti Foundation

Ferrata Storti Foundation

SHERPA: Unknown

People

Tallman
Levine
Zelenetz
Mauro
Stein
Abdel-Wahab
Dogan
Horwitz
Perales
Salles

Groups

Department of Medicine (295)
Hematologic Malignancies, Division of (294)
Center for Hematologic Malignancies (270)
Adult Leukemia (107)
Lymphoma (73)
GSK Faculty (70)
Executive Committee, Center for Hematologic Malignancies (60)
Hematologic Malignancies Research (45)
Sloan Kettering Institute Postdocs (43)
Center for Molecular Imaging and Biotechnology (CMIB) (41)

Search Within

Results (357)

Export to EndNote / Excel

Timing of defibrotide initiation post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after primary chemotherapy: Exploratory analysis of an expanded-access protocol

Meeting Abstract

Kernan, N.; Richardson, P.; Triplett, B.; Grupp, S.; Antin, J.; Liang, W.; Hume, R.; Tappe, W.; Soiffer, R.
Haematologica (2017)

Fulltext@MSK | Save

Multiple myeloma and comorbidity: A population-based study

Meeting Abstract

Sverrisdottir, I. S.; Rögnvaldsson, S.; Lund, S. H.; Turesson, I.; Hultcrantz, M.; Björkholm, M.; Landgren, O.; Kristinsson, S. Y.
Haematologica (2017)

Fulltext@MSK | Save

Defibrotide efficacy and safety in patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) diagnosed after day 21: Analysis of final data from an expanded-access program

Meeting Abstract

Richardson, P.; Smith, A.; Triplett, B.; Kernan, N.; Grupp, S.; Antin, J.; Lehmann, L.; Giralt, S.; Ryan, R.; Hume, R.; more...
Haematologica (2017)

Fulltext@MSK | Save

Prognostic tools can provide personalized outcomes prediction after allogeneic HCT in patients with hematologic malignancies

Meeting Abstract

Cho, C.; Devlin, S.; Hilden, P.; Maloy, M.; Horowitz, M.; Rizzo, J. D.; Logan, B.; Barba, P.; O'Reilly, R.; Giralt, S.; more...
Haematologica (2017)

Fulltext@MSK | Save

Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: Final subgroup results

Meeting Abstract

Richardson, P.; Smith, A.; Triplett, B.; Kernan, N.; Grupp, S.; Antin, J.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; more...
Haematologica (2017)

Fulltext@MSK | Save

Differentiation syndrome associated with enasidenib (AG-221), a selective inhibitor of mutant isocitrate dehydro-genase 2 (mIDH2)

Meeting Abstract

Fathi, A. T.; DiNardo, C. D.; Kline, I.; Kenvin, L.; Gupta, I.; Attar, E. C.; Stein, E. M.; de Botton, S.
Haematologica (2017)

Fulltext@MSK | Save

AICDA drives epigenetic heterogeneity in germinal center-derived lymphomas and accelerates lymphomagenesis

Meeting Abstract

Dominguez, P. M.; Teater, M.; Redmond, D.; Chen, Z.; Ennishi, D.; Scott, D. W.; Cimmino, L.; Ghione, P.; Chaudhuri, J.; Gascoyne, R. D.; more...
Haematologica (2017)

Fulltext@MSK | Save

Improved survival in 21,465 multiple myeloma patients: Results from a population-based study

Meeting Abstract

Thorsteinsdottir, S.; Dickman, P. W.; Turesson, I.; Landgren, O.; Hultcrantz, M.; Björkholm, M.; Kristinsson, S. Y.
Haematologica (2017)

Fulltext@MSK | Save

Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia: Initial results from the BFORE trial

Meeting Abstract

Brümmendorf, T. H.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Reilly, L.; Jeynes-Ellis, A.; Leip, E.; Bardy-Bouxin, N.; more...
Haematologica (2017)

Fulltext@MSK | Save

Risk of thrombosis in patients with non-Hodgkin's lymphoma: A population-based cohort study

Meeting Abstract

Birgisdóttir, A. M.; Sverrisdottir, I. S.; Landgren, O.; Björkholm, M.; Kristinsson, S. Y.
Haematologica (2017)

Fulltext@MSK | Save

Ferrata Storti Foundation – authorized name for:

Ferrata Storti Foundation